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subsequent NVF and mortality within 2 years follow-up. In the no-FLS, only
standard fracture care procedures were followed. In the FLS all patients that
were able and willing to participate had DXA and laboratory testing and, if
applicable, treated according to the Dutch guideline. Subsequent NVF risk and
mortality were compared between both patient groups. Hazard ratios (HR)
were calculated using multivariable Cox regression analyses.
Results: After adjustment for age, gender and baseline fracture location,
HR for NVF in FLS (n = 1412) compared to no FLS (n = 1910) was time-
dependent: 0·84 (95%CI: 0·64–1·10) at 12 months and 0·44 (95%CI: 0·25–0·79)
at 24 months. HR for mortality was 0·65 (95%CI: 0·53–0·79) without effect of
time. HRs were significantly lower for subsequent NVF after hip fracture, and
for mortality after hip or major fractures.
Conclusion: In patients evaluated at the FLS, the risk of subsequent NVF
was 56% lower during the second year and mortality was 35% lower during
the total follow-up of two years. These results indicate that a FLS should be
considered, especially in patients with a hip or other major fracture.
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Introduction: In this study incidence and prognosis of anastomotic leakage
and the development of presacral abscess was assessed.
Methods and patients: From 1994 until 2011, a total of 665 patients
underwent surgery for LARC. A total of 525 patients (323 male, 202 female;
mean age 63 years) who underwent a LAR or APR were included.
Results: The overall incidence of presacral abscess formation was 13·7%
(n = 72). Forty-one patients developed a presacral abscess after LAR, 19
underwent surgical intervention. In 8 patients sacrifice of the anastomoses was
required (3·6%of patients). In the remaining patients conservative treatment
(n = 15) or radiological drainage (n = 28) was sufficient.
The overall incidence of anastomotic leakage was 7·8% (n = 41). 26 patients
required a surgical intervention, in 8 cases (3·6%) the anastomosis was sacrificed.
In the remaining 18 cases a diverting stoma was created or a new anastomoses
was made.
The only significant factor for the development of a presacral abscess we
found is the timing interval between neo-adjuvant radiation and surgery.
When dividing the timing interval into 3 groups (< 6, 6–8 and > 8 weeks) a
significant correlation was found (OR = 7·69, p = 0·001). Significance remained
after dividing the timing interval into 2 groups (< 8, > 8 weeks, OR = 2·41,
p = 0·001). The only prognostic factor for anastomotic leakage we found was
the presence of a presacral abces (OR = 19·83, p = 0·001).
Conclusion: Surgery within 8 weeks of neo-adjuvant treatment is associated
with an increased risk in the development of a presacral abscess. A presacral
abscess should raise suspicion for the presence of an anastomotic leakage, a
significant correlation was found.
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Introduction: The application of neoadjuvant radiotherapy became
widespread after the Dutch TME trail showed neoadjuvant radiotherapy to
lower local recurrence rates. However, the widespread use of neoadjuvant
radiotherapy also introduced a new problem: the treatment of local recurrence
in a previously irradiated area. This study evaluates the results of re-irradiation,
followed by resection of local recurrent rectal cancer in a previously irradiated
area.
Patients and Methods: All patients treated for locally recurrent rectal cancer
between 1998 and 2011 were retrospectively analysed.
Results: Resection of a local recurrence was performed in 110 patients.
Twenty-five patients had received neo-adjuvant radiation therapy for the pri-
mary tumour. Nineteen patients had a minimal potential follow-up of one
year and were considered eligible for evaluation. Surgery was performed in
12 men and 7 women with a median age of 63 (41–76) years. Re-irradiation
dose was 27–30Gy, combined in 9 patients with capecitabine. A R0 resection
was achieved in 3 patients, a R1 resection in 12 patients and a R2 resection
in 4 patients. In all patients with positive margins, intra-operative radiotherapy
was applied. Complications occurred in 10 (52%) patients. Median follow-up
was 23 months. Disease free survival after 1 and 3 years was 61% and 33%,
respectively. Local control was 66% after 1 and 44% after 3 years. The overall
survival was 78% at 1 year and 50% at 3 years.
Conclusion: Re-irradiation followed by resection locally recurrent rectal
cancer in previously irradiated patients is feasible. However, positive resection
margins are common and intra-operative radiotherapy was indicated in the
majority of cases.
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Introduction: Postoperative mortality is frequently used in hospital
comparisons as a marker for quality of care.
Differences may be explained by varying incidence of complications or by failure
to treat complications adequately, referred to as failure-to-rescue (FTR).
Aim of this study is to evaluate whether differences in hospital-mortality after
colorectal surgery correlate with differences in severe complication rates or
FTR. Second objective is to investigate possible differences in FTR after
surgical and non-surgical complications.
Patients and methods: 24667 patients operated for colorectal cancer from
2009–2011, registered in the Dutch Surgical Colorectal Audit, were included.
Adjusted mortality- complication- and FTR-rates were calculated. Hospitals
were grouped into mortality-quintiles. Outcomes were compared between
quintiles. Linear correlations were tested. Analysis of type of complications was
done in patients operated in 2011.
Results: Severe complications ranged from 11 to 16% between the lowest
and highest mortality-quintile (RR = 1,45). Correlation coefficient r was 0·304
(p = 0·003). FTR rates increased from 7 to 21% (RR = 3·0). Linear correlation
was stronger, with r = 0·65 (p < 0,001).
In 2011, 1012 patients had severe complications. FTR rates were 71% following
general-, 9% following surgical- and 28% after both complications. Adjusted
OR of FTR was 5·8 for general compared to surgical complications.
Conclusion: High-mortality hospitals had slightly higher severe complication
than low-mortality hospitals. However, differences in hospital mortality seem
to be correlated strongly with differences in failure-to-rescue, suggesting that
timely recognition and adequately treating complications may be an important
area of improvement for reducing mortality. Attention should be paid to
avoiding death after non-surgical complications.
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